Ask Dr. Gott: Burning sensations related to meds?
Dear Dr. Gott: For the past several months I have been experiencing burning sensations in different areas of my body.
CLSI Publishes Approved Guideline For Continuous Interstitial Glucose Monitoring
Main Category: Diabetes Also Included In: Medical Devices / Diagnostics Article Date: 30 Jan 2009 - 8:00 PST printer friendly view / write opinions rate article Clinical and Laboratory Standards Institute …
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Endo Pharmaceuticals announced today that by mutual agreement it has concluded its research collaboration with Alexza Pharmaceuticals, Inc.
Some antacids may interfere with heart drug
A drug combination prescribed to thousands of heart attack survivors increases the risk of a repeat heart attack, Canadian researchers are warning.
FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD
DEERFIELD, Ill., and OSAKA, Japan, Jan 30, 2009 /PRNewswire via COMTEX/ — First proton pump inhibitor with a Dual Delayed Release formulation Takeda Pharmaceutical Company Limited and its wholly-owned …
Proposed state law would change how Gaston County euthanizes animals at shelter
Animal shelters in North Carolina would be prohibited from using carbon monoxide or any other gas when they euthanize animals under a proposed new state law.
Teva Announces Approval of Generic Risperdal Oral Solution
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company’s Abbreviated New Drug Application to market its generic version of …
Possible Case: Darvocet
FDA Expert Panel Votes for Ban
FDA: Eli Lilly blood thinner has clear benefits
Federal health officials said Friday a blood thinner from Eli Lilly offers life-saving benefits over drugs currently on the market, though its use may have to be restricted due to bleeding side effects.
Special Committee of Genentech Board of Directors Responds to Roche’s Announced Intention to Commence a Tender Offer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Jan 30, 2009 - The special committee of the Board of Directors of Genentech, Inc. (NYSE:DNA) today urged shareholders to take no action at this time with respect to the announcement by Roche that it…